ibandronate sodium

(redirected from Boniva Injection)

ibandronate sodium

(ī-băn′drə-nāt′)
n.
A bisphosphonate drug that inhibits bone resorption, given monthly to treat and prevent osteoporosis primarily in postmenopausal women.
Mentioned in ?
References in periodicals archive ?
Nasdaq: MYL) today announced that it has launched Ibandronate Sodium Injection, 1 mg (base)/mL, packaged in 3 mg (base)/3 mL pre-filled glass syringes, which is the generic version of Hoffmann-La Roche's Boniva Injection.
The Triad Group alcohol prep pads are co-packaged and distributed with Genentech medicines, Boniva Injection, Fuzeon, Nutropin A.
The company plans to issue a Dear Healthcare Provider letter to potential prescribers and pharmacists to make them aware of the Triad product recall and the need to discontinue use of the alcohol prep pads packaged with Boniva Injection, Fuzeon, Nutropin A.
Boniva Injection, the first quarterly medication for the treatment of postmenopausal osteoporosis, is a member of the bisphosphonate class, which is the most frequently prescribed medicine for osteoporosis.
Additionally, because Boniva Injection will be administered by healthcare professionals, clinicians will have a greater awareness of patient compliance with therapy.
Approval of Boniva Injection and once-monthly oral Boniva follow a Surgeon General's Report that elevated osteoporosis to a major public health threat on par with smoking and obesity.
We welcome any new treatment options such as Boniva Injection that will help patients address this all too prevalent disease," said Judith Cranford, Executive Director, National Osteoporosis Foundation.
Boniva Injection (3 mg once every three months) was approved based on results from the DIVA study, a randomized, double-blind, multinational, non-inferiority trial in 1,358 women with postmenopausal osteoporosis who were treated with either an IV injection or the once-daily oral formulation of Boniva.
DIVA showed that the average increase in lumbar spine BMD at one year in patients treated with Boniva Injection (3 mg once every three months) was statistically superior to that in patients treated with the daily oral tablets (4.
Boniva Injection is indicated for the treatment of osteoporosis in postmenopausal women.
In a one-year study comparing Boniva Injection and Boniva Tablets 2.